<DOC>
	<DOCNO>NCT01995331</DOCNO>
	<brief_summary>Severe aplastic anemia ( SAA ) characterize depletion hematopoietic precursor associate life-threatening complication . High-dose cyclophosphamide find yield complete response ( CR ) adult child SAA.However , optimal dosage cyclophosphamide patient childhood remain unclear . So explore ideal dosage cyclophosphamide treatment child SAA .</brief_summary>
	<brief_title>Moderate-dose Cyclophosphamide Childhood Acquired Aplastic Anemia</brief_title>
	<detailed_description>Tisdale et al . ( 2000,2002 ) attempt compare immunosuppression use ATG/CSA high-dose cyclophosphamide ( 50 mg/kg/d 4 consecutive day ) plus CSA randomize trial newly diagnose adult SAA . Both group receive CSA part treatment regimen . However , trial terminate prematurely due excessive morbidity among patient treat cyclophosphamide arm . They document invasive fungal infection severe among cyclophosphamide group . Between January 2008 May 2009 , department , nine pediatric patient diagnosis SAA enrol study lower dose cyclophosphamide 30mg/kg/day 4 consecutive day combination CSA , study show promise child severe aplastic anemia.Now want explore dosage cyclophosphamide .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Acquired Childhood Severe Aplastic Anemia ( SAA ) Childhood Acquired Severe Aplastic Anemia</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>aplastic anemia ;</keyword>
	<keyword>cyclophosphamide ;</keyword>
	<keyword>immunosuppressive therapy ;</keyword>
	<keyword>cyclosporine A</keyword>
</DOC>